APA

Mills A., Mildvan D., Podzamczer D., Fätkenheuer G., Leal M., Than S., Valluri S. R., Craig C., McFadyen L., Vourvahis M., Heera J., Valdez H., Rinehart A. R. & Portsmouth S. (20130308). Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Mills Anthony, Mildvan Donna, Podzamczer Daniel, Fätkenheuer Gerd, Leal Manuel, Than Soe, Valluri Srinivas R, Craig Charles, McFadyen Lynn, Vourvahis Manoli, Heera Jayvant, Valdez Hernan, Rinehart Alex R and Portsmouth Simon. 20130308. Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Mills A., Mildvan D., Podzamczer D., Fätkenheuer G., Leal M., Than S., Valluri S. R., Craig C., McFadyen L., Vourvahis M., Heera J., Valdez H., Rinehart A. R. and Portsmouth S. (20130308). Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study. : Journal of acquired immune deficiency syndromes (1999).

MLA

Mills Anthony, Mildvan Donna, Podzamczer Daniel, Fätkenheuer Gerd, Leal Manuel, Than Soe, Valluri Srinivas R, Craig Charles, McFadyen Lynn, Vourvahis Manoli, Heera Jayvant, Valdez Hernan, Rinehart Alex R and Portsmouth Simon. Maraviroc once-daily nucleoside analog-sparing regimen in treatment-naive patients: randomized, open-label pilot study. : Journal of acquired immune deficiency syndromes (1999). 20130308.